Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CARDIX-101 by Cardix Therapeutics for Bradycardia: Likelihood of Approval
CARDIX-101 is under clinical development by Cardix Therapeutics and currently in Phase II for Bradycardia. According to GlobalData, Phase II...